Merck and International Diabetes Federation Partner to Help Address Global Type 2 Diabetes Epidemic

PR70995

DARMSTADT, Germany, Nov.13, 2017/PRNewswire=KYODO JBN/--

The information contained in this release is not appropriate for audiences in

the USA and Canada     

- Focus on education and awareness-raising initiatives to facilitate prevention

  of type 2 diabetes  

- Partnership activities include online course for healthcare professionals and

  joint awareness campaign on World Diabetes Day 14 November 2017

Merck, a leading science and technology company with 60 years of clinical

experience in diabetes, today announced its partnership with the International

Diabetes Federation (IDF) to implement education and communications activities

emphasizing the importance of preventing type 2 diabetes. The IDF recognize

diabetes overall as one of the largest global health emergencies of the 21st

century[1] and type 2 diabetes is the most common form of diabetes, estimated

to contribute to up to 90% of global diabetes cases.[1] Yet many cases of type

2 diabetes can be delayed or prevented.[1]

     (Photo:

http://mma.prnewswire.com/media/601689/Merck_Belen_Garijo_Infographic.jpg )

     (Photo:

http://mma.prnewswire.com/media/601688/Merck_Shaukat_Sadikot_Infographic.jpg )

"Merck shares the International Diabetes Federation's vision of promoting

diabetes care and prevention worldwide, and we are committed to helping improve

the lives of people living with or at risk of type 2 diabetes," said Belén

Garijo, M.D., member of the Executive Board and CEO Healthcare at Merck. "The

IDF's prestigious platforms, such as the online School of Diabetes and World

Diabetes Day, provide a valued way for our joint education and awareness

initiatives to reach and empower people with the knowledge they need in the

fight against diabetes."

The first partnership activity, available now on the IDF's School of Diabetes

website, is a CME accredited, IDF-certified healthcare professional (HCP)

course about prevention of type 2 diabetes developed with an educational grant

from Merck, which enables unlimited access for HCPs globally. The IDF's online

school, www.idfdiabeteschool.org, is a one-stop portal that gives access to

up-to-date, evidence-based information on all aspects of diabetes care,

management and prevention, which is developed and reviewed by world-leading

specialists.[2]

Dr. Shaukat Sadikot, President of IDF, says, "The world is facing a rising

prevalence and incidence of type 2 diabetes, due to limited knowledge on

prevention and insufficiently informed self-management. Healthcare

professionals have an important role to play to tackle this issue. Our

self-paced online short course aims to enhance their knowledge and provide

evidence-based strategies for the prevention of type 2 diabetes."

Merck's partnership with the IDF extends to World Diabetes Day 2017 (14

November), which is themed 'Women and diabetes.' Merck is committed to and

involved in raising awareness about women's health with the program Healthy

Women, Healthy Economies [http://healthywomen.apec.org/]. Alongside the IDF,

Merck is proud to support the global awareness-raising initiative to promote

healthier lifestyles for women at risk of or living with diabetes globally and

advocate prevention. The IDF estimate that there are currently over 199 million

women living with diabetes worldwide and this number is projected to increase

to 313 million by 2040.[1]

Merck's close collaboration with the IDF is another way that the company is

demonstrating its commitment to improving the lives of people living with

diabetes. To learn more about Merck's commitment to diabetes, please visit

www.merckgroup.com.

About IDF  

The International Diabetes Federation (IDF) is an umbrella organization of over

230 national diabetes associations in 165 countries and territories. It

represents the interests of the growing number of people with diabetes and

those at risk. The Federation has been leading the global diabetes community

since 1950. The Federation's activities aim to influence policy, increase

public awareness and encourage health improvement, promote the exchange of

high-quality information about diabetes, and provide education for people with

diabetes and their healthcare providers. IDF is associated with the Department

of Public Information of the United Nations and is in official relations with

the World Health Organization (WHO). http://www.idf.org.

Merck in Diabetes  

In 2015, there were an estimated 415 million adults aged 20-79 with diabetes,

and the World Health Organization (WHO) projects that diabetes will be the

seventh leading cause of death in 2030.[3] By 2040, that number is expected to

rise to 642 million - over 10% of the world's adult population.[1] Type 2

diabetes is the more common form, and while its causes are partly genetic, [1]

lifestyle factors - such as obesity, poor nutrition, and lack of exercise -

also play a major role.[1]

Type 2 diabetes can produce a range of complications including cardiovascular

diseases, eye damage, and kidney disease.[1] Most worryingly, only one in two

sufferers has been diagnosed.[1] Merck is committed to improving the lives of

people living with diabetes.

All Merck Press Releases are distributed by e-mail at the same time they become

available on the Merck Website. Please go to

http://www.merckgroup.com/subscribe to register online, change your selection

or discontinue this service.

About Merck

Merck is a leading science and technology company in healthcare, life science

and performance materials. Around 50,000 employees work to further develop

technologies that improve and enhance life - from biopharmaceutical therapies

to treat cancer or multiple sclerosis, cutting-edge systems for scientific

research and production, to liquid crystals for smartphones and LCD

televisions. In 2016, Merck generated sales of €15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical

company. The founding family remains the majority owner of the publicly listed

corporate group. The company holds the global rights to the Merck name and

brand. The only exceptions are the United States and Canada, where the company

operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

References

1. IDF Diabetes Atlas. 7th edition. 2015. Available at:

http://www.diabetesatlas.org/ Last accessed September 2017

2. IDF School of Diabetes website. Available at:

https://www.idfdiabeteschool.org/CertificateCourse

Last accessed September 2017

3. Mathers CD, Loncar D. PLoS Med, Projections of global mortality and burden

of disease from 2002 to 2030. 2006, 3(11):e442

     (Logo: http://mma.prnewswire.com/media/472778/Merck_Logo.jpg )

     (Logo: http://mma.prnewswire.com/media/601687/IDF_Logo.jpg )

Source: Merck KGaA